On August 21, Baheal Medical and Gilead Sciences signed a strategic cooperation agreement. This collaboration will leverage Baheal Medical's professional commercialization capabilities and its nationwide retail terminal marketing network in China, combined with Gilead Sciences' cutting-edge knowledge and extensive experience in disease areas such as virology. Both parties will jointly explore innovative medical solutions and service models to enhance the accessibility of innovative drugs, increase disease awareness, and ensure medication safety.

